Results

Total Results: 1,078 records

Showing results for "stage".

  1. effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and … Hoskin, 201219 -- n = 218 EBRT: n = 108 EBRT + high- dose-rate brachytherapy boost: n = 110 Stage … Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and … Hoskin, 201219 -- n = 218 EBRT: n = 108 EBRT + high- dose-rate brachytherapy boost: n = 110 Stage … Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d3.xlsx
    January 01, 2025 - 0.95 0.78 1.46 NR NR 795 Yes NR NR Adjusted : baseline toxicity scores, age, PSA, Gleason score, T stage … 0.95 1.16 2.13 NR NR 795 Yes NR NR Adjusted : baseline toxicity scores, age, PSA, Gleason score, T stage … 1.18 NR NR 804 Yes NR NR Adjusted : Risk group, Interaction : Age, Gleason score, risk group, PSA, T-stage … 1.09 NR NR 804 Yes NR NR Adjusted : Risk group, Interaction : Age, Gleason score, risk group, PSA, T-stage … analyses reported but interaction p-values NS: baseline and acute GU symptoms, PSA, Gleason score, T stage
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
    October 01, 2014 - It is refreshing to see concerns of patient anxiety and quality of life sharing the stage with the … That is, changes in therapeutic management or stage reclassification are appropriate terminal points
  5. effectivehealthcare.ahrq.gov/sites/default/files/methodsguidenorris_060420101.pdf
    June 01, 2010 - consultation with clinical experts may also identify important gaps in the RCT evidence at the protocol stage … registry in the United States that enrolls patients who have received ventricular assist devices for end-stage … Well-known or large RCTs should be examined in detail at this stage.
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
    June 01, 2010 - consultation with clinical experts may also identify important gaps in the RCT evidence at the protocol stage … registry in the United States that enrolls patients who have received ventricular assist devices for end-stage … Well-known or large RCTs should be examined in detail at this stage.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/clinical-care-protocol.pdf
    January 01, 2024 - feature of DistillerSR (AI Classifier Manager) as a second reviewer at the title and abstract screening stage … semi-automated screening tool to conduct the review efficiently at the title and abstract screening stage
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
    June 15, 2016 - following population and study characteristics: sex, disease subtype (lateral, patellofemoral), severity (stage … or study characteristics: sex, disease subtype (lateral tibiofemoral, patellofemoral), severity (stage … of Orthopaedic Surgeons (AAOS, 2013), ACR clinical classification criteria,29 or Kellgren-Lawrence stage … defined by sex, disease subtype (e.g., patellofemoral, or medial tibiofemoral), disease severity (stage … populations, studies that enroll younger age populations (mean age less than 50), those with only early stage
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-immunodeficiency-virus-rapid-response.pdf
    May 01, 2025 - This acute stage of HIV is followed by a chronic or clinical latent stage where the virus continues
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
    February 01, 2012 - In the first stage of this Future Research Needs report, we engaged a group of Key Informants to help … As is detailed in the Methods section, in the first stage of this future research needs report, we … High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma … Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma. … To determine the survival outcomes of stage 4a retinoblastoma patients following treatment with
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_disposition-comments.pdf
    July 26, 2012 - the more direct patient-centered outcome is clinically meaningful kidney damage (e.g. incident end stage … renal disease, progression to stage 4 CKD or worse, developing of acute renal failure requiring hospitalization … incident end stage renal disease, progression to stage 4 CKD or worse, developing of acute renal failure … Peer Reviewer #3 Discussion Using acute renal failure or end stage renal disease as outcomes is impractical
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-265-radiation-bone-disease-disposition-comments.pdf
    August 29, 2023 - The introduction necessarily focuses on setting the stage for the key questions for the review. … The introduction necessarily focuses on setting the stage for the key questions for the review.
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/assessing-the-risk-of-bias-in-systematic-reviews-of-health-care-interventions-01_0.pdf
    May 01, 2005 - Assessing-The-Risk-Of-Bias-In-Systematic-Reviews-Of-Health-Care-Interventions Methods Guide for Comparative Effectiveness Reviews Assessing the Risk of Bias in Systematic Reviews of Health Care Interventions This report is based on research conducted b…
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-failure-rescue-protocol-amendment.pdf
    September 19, 2023 - feature of DistillerSR (AI Classifier Manager) as a second reviewer at the title and abstract screening stage … semi-automated screening tool to conduct this review efficiently at the title and abstract screening stage
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-repository-expanded-protocol.pdf
    October 24, 2019 - One investigator will determine eligibility at the title/abstract review stage and a second investigator … For studies included at the title/abstract review stage, the full-text will be retrieved and reviewed
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
    January 01, 2023 - intensity index (0-100 scale; converted to 0-10 scale) 4.4 (SD 1.46) Propensity matched on age, gender, stage … 0 to 100 VAS): 43.3 (14.0) vs. 43.1 (14.0) Overall mean: 43.2 (SD 14.0) Age, gender, pain severity, stage
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-table-F5.xlsx
    January 01, 2022 - intensity index (0-100 scale; converted to 0-10 scale) 4.4 (SD 1.46) Propensity matched on age, gender, stage … 0 to 100 VAS): 43.3 (14.0) vs. 43.1 (14.0) Overall mean: 43.2 (SD 14.0) Age, gender, pain severity, stage
  18. effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
    July 09, 2013 - The flutemetamol developers believe it will be able to differentiate early stage AD from absence of
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
    February 01, 2012 - Assessment Major elements for data abstraction were patient characteristics (i.e., age, sex, disease stage … We attempted to identify subgroups based on prognostic factors such as tumor stage or location in solid
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_research-protocol.pdf
    October 01, 2013 - induced nephropathy (CIN), for the outcomes of incidence of CIN, chronic kidney disease (CKD), end stage … hospital stay Long-term (> 7 days): a) Renal function measures ● Development of CKD, including end stage … AKI=acute kidney injury; CIN=contrast induces nephropathy; CKD=chronic kidney disease; ESRD=end stage … AKI=acute kidney injury; CIN=contrast induces nephropathy; CKD=chronic kidney disease; ESRD=end stage

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: